Steward Partners Investment Advisory’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $154K | Buy |
3,031
+981
| +48% | +$49.9K | ﹤0.01% | 1881 |
|
|
2025
Q1 | $92.4K | Sell |
2,050
-750
| -27% | -$33.8K | ﹤0.01% | 2058 |
|
|
2024
Q4 | $116K | Sell |
2,800
-5,864
| -68% | -$242K | ﹤0.01% | 1907 |
|
|
2024
Q3 | $338K | Sell |
8,664
-27,186
| -76% | -$1.06M | ﹤0.01% | 1279 |
|
|
2024
Q2 | $1.23M | Sell |
35,850
-20,850
| -37% | -$713K | 0.01% | 744 |
|
|
2024
Q1 | $1.42M | Buy |
56,700
+17,150
| +43% | +$431K | 0.02% | 682 |
|
|
2023
Q4 | $1.17M | Buy |
39,550
+9,500
| +32% | +$280K | 0.02% | 674 |
|
|
2023
Q3 | $950K | Buy |
30,050
+21,050
| +234% | +$665K | 0.01% | 692 |
|
|
2023
Q2 | $233K | Sell |
9,000
-500
| -5% | -$12.9K | ﹤0.01% | 1214 |
|
|
2023
Q1 | $228K | Hold |
9,500
| – | – | ﹤0.01% | 1220 |
|
|
2022
Q4 | $185K | Buy |
9,500
+2,150
| +29% | +$41.9K | ﹤0.01% | 1273 |
|
|
2022
Q3 | $154K | Buy |
7,350
+6,350
| +635% | +$133K | ﹤0.01% | 1310 |
|
|
2022
Q2 | $19K | Sell |
1,000
-1,000
| -50% | -$19K | ﹤0.01% | 2248 |
|
|
2022
Q1 | $44K | Sell |
2,000
-3,000
| -60% | -$66K | ﹤0.01% | 1977 |
|
|
2021
Q4 | $80K | Sell |
5,000
-250
| -5% | -$4K | ﹤0.01% | 1689 |
|
|
2021
Q3 | $105K | Buy |
5,250
+2,250
| +75% | +$45K | ﹤0.01% | 1520 |
|
|
2021
Q2 | $52K | Buy |
+3,000
| New | +$52K | ﹤0.01% | 3279 |
|
|
2021
Q1 | – | Sell |
-2,500
| Closed | -$44K | – | 3464 |
|
|
2020
Q4 | $44K | Buy |
+2,500
| New | +$44K | ﹤0.01% | 1722 |
|